BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 3, 2018
View Archived Issues
Separating graft attacks
Read More
BBB fails to slow down prions
Read More
Engineered oncolytic virus sticks with glioblastoma
Read More
Bayer initiates phase I II study of factor VIII gene transfer therapy with BAY-2599023
Read More
TRACON and I-Mab Biopharma enter immuno-oncology partnership
Read More
Identification of the PANK activator PZ-2891 for pantothenate kinase-associated neurodegeneration
Read More
Zogenix presents phase III data for fenfluramine in children and young adults with Dravet syndrome
Read More
First patient dosed in alloSHRINK phase I study of CYAD-101
Read More
Salivary RNA test developed for diagnosing childhood autism spectrum disorder
Read More
Bristol-Myers Squibb patents IRAK-4 inhibitors
Read More
Enanta Pharmaceuticals discloses MAP3K5 inhibitors
Read More
CD73 inhibitors reported in Eternity Bioscience patent
Read More
FDA clears IND application to initiate phase I/II study of KRAS G12C inhibitor, MRTX-849
Read More
ORIC Pharmaceuticals synthesizes CD73 inhibitors
Read More
Guangzhou Wellhealth Bio-Pharmaceutical divulges PARP-1 inhibitors
Read More
First subject successfully enrolled in first-in-human study of AT-1501 as treatment for ALS
Read More
Targeting the chromatin assembly factor complex blocks leukemia development in mice
Read More
Pain Therapeutics begins phase IIa study of PTI-125 in mild to moderate Alzheimer's disease
Read More
Bayer presents first phase I data for BAY-1093884 in patients with hemophilia
Read More
Leo Pharma initiates phase IIb studies of delgocitinib for atopic dermatitis and chronic hand eczema
Read More
ASH 2018: CRISPR screening gives clues to drug sensitivities of rare AML subtype
Read More
Biohaven reports topline data from phase III study of Zydis ODT rimegepant for acute migraine
Read More
Researchers present data for S-63845 in B-cell precursor ALL
Read More
Sienna reports phase IIb topline data on SNA-120 in psoriasis
Read More
Phase III ERADICATE Hp2 study of Talicia meets primary endpoint of H. pylori eradication
Read More
FDA approves Dextenza intracanalicular insert to treat postsurgical ocular pain
Read More
New phase II investigator-initiated study evaluates nitazoxanide in NASH-induced fibrosis
Read More